2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC)

<jats:p>.</jats:p>

[1]  ESC / EAS Guidelines for the Treatment of Dyslipidemias: Lipid Modification to Reduce Cardiovascular Risk , 2020, Digital Doctor.

[2]  A. Hess,et al.  Management. , 2020, Anesthesiology.

[3]  Jeroen J. Bax,et al.  Impact of a decreasing pre-test probability on the performance of diagnostic tests for coronary artery disease. , 2019, European heart journal cardiovascular Imaging.

[4]  A. Parkhomenko,et al.  Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation , 2019, The New England journal of medicine.

[5]  Katie Myers Smith,et al.  A Randomized Trial of E‐Cigarettes versus Nicotine‐Replacement Therapy , 2019, The New England journal of medicine.

[6]  L. Køber,et al.  Fractional flow reserve-guided percutaneous coronary intervention vs. medical therapy for patients with stable coronary lesions: meta-analysis of individual patient data , 2018, European heart journal.

[7]  E. Prescott,et al.  Prediction of obstructive coronary artery disease and prognosis in patients with suspected stable angina. , 2018, European heart journal.

[8]  Michael T. Lu,et al.  Pretest probability for patients with suspected obstructive coronary artery disease: re-evaluating Diamond-Forrester for the contemporary era and clinical implications: insights from the PROMISE trial. , 2018, European heart journal cardiovascular Imaging.

[9]  Christopher J. Rush,et al.  Stratified Medical Therapy Using Invasive Coronary Function Testing in Angina: The CorMicA Trial. , 2018, Journal of the American College of Cardiology.

[10]  G. Lip,et al.  Should the Presence or Extent of Coronary Artery Disease be Quantified in the CHA2DS2-VASc Score in Atrial Fibrillation? A Report from the Western Denmark Heart Registry , 2018, Thrombosis and Haemostasis.

[11]  R. Stewart,et al.  Physical activity and mortality in patients with stable coronary heart disease , 2018, Current opinion in cardiology.

[12]  S. Hess,et al.  Prospective Comparison of FFR Derived From Coronary CT Angiography With SPECT Perfusion Imaging in Stable Coronary Artery Disease: The ReASSESS Study. , 2018, JACC. Cardiovascular imaging.

[13]  D. Andreini,et al.  Coronary computed tomography angiography for heart team decision-making in multivessel coronary artery disease , 2018, European heart journal.

[14]  C. Terkelsen,et al.  Coronary CT Angiographic and Flow Reserve-Guided Management of Patients With Stable Ischemic Heart Disease. , 2018, Journal of the American College of Cardiology.

[15]  J. Iqbal,et al.  Study of Two Dose Regimens of Ticagrelor Compared With Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention for Stable Coronary Artery Disease , 2018, Circulation.

[16]  A. Editorial.  2017 ESC FOCUSED UPDATE ON DUAL ANTIPLATELET THERAPY IN CORONARY ARTERY DISEASE DEVELOPED IN COLLABORATION WITH EACTS , 2018, Russian Journal of Cardiology.

[17]  E. V. van Beek,et al.  Coronary CT Angiography and 5‐Year Risk of Myocardial Infarction , 2018, The New England journal of medicine.

[18]  Binita Shah,et al.  An Update on Radial Artery Access and Best Practices for Transradial Coronary Angiography and Intervention in Acute Coronary Syndrome: A Scientific Statement From the American Heart Association , 2018, Circulation. Cardiovascular interventions.

[19]  D. Newby,et al.  Comparison of International Guidelines for Assessment of Suspected Stable Angina , 2018, JACC. Cardiovascular imaging.

[20]  A. Jeremias,et al.  Validation of a novel non-hyperaemic index of coronary artery stenosis severity: the Resting Full-cycle Ratio (VALIDATE RFR) study. , 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[21]  K. Choi,et al.  Prognostic Implication of Thermodilution Coronary Flow Reserve in Patients Undergoing Fractional Flow Reserve Measurement. , 2018, JACC. Cardiovascular interventions.

[22]  Jeroen J. Bax,et al.  Left ventricular global longitudinal strain is predictive of all-cause mortality independent of aortic stenosis severity and ejection fraction , 2018, European heart journal cardiovascular Imaging.

[23]  Sean M. O'Brien,et al.  International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design , 2018, American heart journal.

[24]  T. Henry,et al.  Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trials , 2018, European heart journal.

[25]  D. Andreini,et al.  Fractional Flow Reserve Derived From Computed Tomographic Angiography in Patients With Multivessel CAD. , 2018, Journal of the American College of Cardiology.

[26]  Jeroen J. Bax,et al.  The performance of non-invasive tests to rule-in and rule-out significant coronary artery stenosis in patients with stable angina: a meta-analysis focused on post-test disease probability , 2018, European heart journal.

[27]  G. Rioufol,et al.  Five‐Year Outcomes with PCI Guided by Fractional Flow Reserve , 2018, The New England journal of medicine.

[28]  R. Senior,et al.  Cost-effectiveness of a management strategy based on exercise echocardiography versus exercise electrocardiography in patients presenting with suspected angina during long term follow up: A randomized study. , 2018, International journal of cardiology.

[29]  M. van der Schaar,et al.  Sex Differences in Outcomes After STEMI: Effect Modification by Treatment Strategy and Age , 2018, JAMA internal medicine.

[30]  A. Barry,et al.  Long‐Term Beta‐Blocker Therapy after Myocardial Infarction in the Reperfusion Era: A Systematic Review , 2018, Pharmacotherapy.

[31]  Zhiyun Xu,et al.  Effect of Ticagrelor Plus Aspirin, Ticagrelor Alone, or Aspirin Alone on Saphenous Vein Graft Patency 1 Year After Coronary Artery Bypass Grafting: A Randomized Clinical Trial , 2018, JAMA.

[32]  William J. Astle,et al.  Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies , 2018, The Lancet.

[33]  M. Shapiro,et al.  Risk of All‐Cause Mortality in Diabetic Patients Taking &bgr;‐Blockers , 2018, Mayo Clinic proceedings.

[34]  F. Alla,et al.  Clinical Events After Discontinuation of &bgr;-Blockers in Patients Without Heart Failure Optimally Treated After Acute Myocardial Infarction: A Cohort Study on the French Healthcare Databases , 2018, Circulation. Cardiovascular quality and outcomes.

[35]  D. Lloyd‐Jones,et al.  Association of Body Mass Index With Lifetime Risk of Cardiovascular Disease and Compression of Morbidity , 2018, JAMA cardiology.

[36]  H. Bøtker,et al.  Diagnosing coronary artery disease after a positive coronary computed tomography angiography: the Dan-NICAD open label, parallel, head to head, randomized controlled diagnostic accuracy trial of cardiovascular magnetic resonance and myocardial perfusion scintigraphy , 2018, European heart journal cardiovascular Imaging.

[37]  Deepak L. Bhatt,et al.  Major Adverse Limb Events and Mortality in Patients With Peripheral Artery Disease: The COMPASS Trial. , 2018, Journal of the American College of Cardiology.

[38]  S. Piechnik,et al.  Diagnosis of Microvascular Angina Using Cardiac Magnetic Resonance , 2018, Journal of the American College of Cardiology.

[39]  E. Prescott,et al.  The prognostic value of coronary endothelial and microvascular dysfunction in subjects with normal or non-obstructive coronary artery disease: A systematic review and meta-analysis. , 2018, International journal of cardiology.

[40]  Dimitris Mavridis,et al.  Outcomes of non-invasive diagnostic modalities for the detection of coronary artery disease: network meta-analysis of diagnostic randomised controlled trials , 2018, British Medical Journal.

[41]  John P. A. Ioannidis,et al.  Effect of Low-Fat vs Low-Carbohydrate Diet on 12-Month Weight Loss in Overweight Adults and the Association With Genotype Pattern or Insulin Secretion: The DIETFITS Randomized Clinical Trial , 2018, JAMA.

[42]  Deepak L. Bhatt,et al.  Ticagrelor for Secondary Prevention of Atherothrombotic Events in Patients With Multivessel Coronary Disease. , 2018, Journal of the American College of Cardiology.

[43]  M. Sørensen,et al.  Environmental Noise and the Cardiovascular System. , 2018, Journal of the American College of Cardiology.

[44]  J. Ferreira,et al.  Influenza vaccination and prevention of cardiovascular disease mortality , 2018, The Lancet.

[45]  Catharine I Paules,et al.  Influenza vaccination and prevention of cardiovascular disease mortality – Authors' reply , 2018, The Lancet.

[46]  F. Crea,et al.  Expert consensus document: A 'diamond' approach to personalized treatment of angina , 2018, Nature Reviews Cardiology.

[47]  H. Huikuri,et al.  Effect of Changes in Physical Activity on Risk for Cardiac Death in Patients With Coronary Artery Disease. , 2018, The American journal of cardiology.

[48]  G. Hindricks,et al.  2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). , 2018, European heart journal.

[49]  S. Thom,et al.  Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial , 2018, The Lancet.

[50]  A. Boyle,et al.  Percutaneous coronary intervention versus coronary artery bypass grafting in heart transplant recipients with coronary allograft vasculopathy: a systematic review and meta-analysis of 1,520 patients. , 2018, Annals of cardiothoracic surgery.

[51]  A. Keszei,et al.  Use of two‐dimensional speckle tracking echocardiography to predict cardiac events: Comparison of patients with acute myocardial infarction and chronic coronary artery disease , 2018, Clinical cardiology.

[52]  L. Badimón,et al.  Acute Coronary Syndrome: The Risk to Young Women , 2017, Journal of the American Heart Association.

[53]  L. Wilkins.  Impact of Diabetes Mellitus on the Evaluation of Stable Chest Pain Patients: Insights From the PROMISE (Prospective Multicenter Imaging Study for Evaluation of Chest Pain) Trial , 2017, Journal of the American Heart Association.

[54]  Michael T. Lu,et al.  Central Core Laboratory versus Site Interpretation of Coronary CT Angiography: Agreement and Association with Cardiovascular Events in the PROMISE Trial. , 2017, Radiology.

[55]  M. Oudkerk,et al.  Diagnostic performance of semi-quantitative and quantitative stress CMR perfusion analysis: a meta-analysis , 2017, Journal of Cardiovascular Magnetic Resonance.

[56]  M. Motwani,et al.  Role of cardiovascular magnetic resonance in the management of patients with stable coronary artery disease , 2017, Heart.

[57]  Michael T. Lu,et al.  Prognostic Value of Coronary Artery Calcium in the PROMISE Study (Prospective Multicenter Imaging Study for Evaluation of Chest Pain) , 2017, Circulation.

[58]  E. Prescott,et al.  Sex-Related Differences in Vasomotor Function in Patients With Angina and Unobstructed Coronary Arteries. , 2017, Journal of the American College of Cardiology.

[59]  F. Flachskampf,et al.  EACVI appropriateness criteria for the use of transthoracic echocardiography in adults: a report of literature and current practice review , 2017, European heart journal cardiovascular Imaging.

[60]  J. Zamorano,et al.  Clinical practice of contrast echocardiography: recommendation by the European Association of Cardiovascular Imaging (EACVI) 2017. , 2017, European heart journal cardiovascular Imaging.

[61]  B. Gaszner,et al.  Effectiveness and safety of anti-ischemic trimetazidine in patients with stable angina pectoris and Type 2 diabetes. , 2017, Journal of comparative effectiveness research.

[62]  Jeroen J. Bax,et al.  Prognostic Value of Coronary CT Angiography With Selective PET Perfusion Imaging in Coronary Artery Disease. , 2017, JACC. Cardiovascular imaging.

[63]  A. Jeremias,et al.  Agreement of the Resting Distal to Aortic Coronary Pressure With the Instantaneous Wave-Free Ratio. , 2017, Journal of the American College of Cardiology.

[64]  Robert S. Huckman,et al.  Making Patients and Doctors Happier - The Potential of Patient-Reported Outcomes. , 2017, The New England journal of medicine.

[65]  V. Reddy,et al.  The Clinical Use of Ivabradine. , 2017, Journal of the American College of Cardiology.

[66]  Sidney C. Smith,et al.  2017 Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. , 2017, Journal of the American College of Cardiology.

[67]  J. Leipsic,et al.  Comparison of Coronary CT Angiography, SPECT, PET, and Hybrid Imaging for Diagnosis of Ischemic Heart Disease Determined by Fractional Flow Reserve , 2017, JAMA cardiology.

[68]  M. Banach,et al.  Optimizing Cholesterol Treatment in Patients With Muscle Complaints. , 2017, Journal of the American College of Cardiology.

[69]  H. Crijns,et al.  Comparison of the prognostic value of negative non-invasive cardiac investigations in patients with suspected or known coronary artery disease–a meta-analysis , 2017, European heart journal cardiovascular Imaging.

[70]  Qing Zhang,et al.  Comparison of coronary artery bypass grafting and drug-eluting stents in patients with chronic kidney disease and multivessel disease: A meta-analysis. , 2017, European journal of internal medicine.

[71]  F. Khasawneh,et al.  Impact of Electronic Cigarettes on the Cardiovascular System , 2017, Journal of the American Heart Association.

[72]  Deepak L. Bhatt,et al.  Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease , 2017, The New England journal of medicine.

[73]  Helmut Baumgartner,et al.  [2017 ESC/EACTS Guidelines for the management of valvular heart disease]. , 2017, Kardiologia polska.

[74]  H. Gransar,et al.  Diagnostic Performance of Hybrid Cardiac Imaging Methods for Assessment of Obstructive Coronary Artery Disease Compared With Stand-Alone Coronary Computed Tomography Angiography: A Meta-Analysis. , 2017, JACC. Cardiovascular imaging.

[75]  C. Held,et al.  Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary Disease. , 2017, Journal of the American College of Cardiology.

[76]  S. Underwood,et al.  Systematic review of cost-effectiveness of myocardial perfusion scintigraphy in patients with ischaemic heart disease: A report from the cardiovascular committee of the European Association of Nuclear Medicine. Endorsed by the European Association of Cardiovascular Imaging. , 2017, European heart journal cardiovascular Imaging.

[77]  I. Barbash,et al.  The Prognostic Effects of Coronary Disease Severity and Completeness of Revascularization on Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement. , 2017, JACC. Cardiovascular interventions.

[78]  P. Austin,et al.  Comparison of Anatomic and Clinical Outcomes in Patients Undergoing Alternative Initial Noninvasive Testing Strategies for the Diagnosis of Stable Coronary Artery Disease , 2017, Journal of the American Heart Association.

[79]  S. Yusuf,et al.  Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials , 2017, The Lancet.

[80]  S. Solomon,et al.  Impact of eplerenone on cardiovascular outcomes in heart failure patients with hypokalaemia , 2017, European journal of heart failure.

[81]  R. Palma dos Reis,et al.  Genetic risk score and cardiovascular mortality in a southern european population with coronary artery disease , 2017, International journal of clinical practice.

[82]  A. Lerman,et al.  Targeting the dominant mechanism of coronary microvascular dysfunction with intracoronary physiology tests , 2017, The International Journal of Cardiovascular Imaging.

[83]  R. Puri,et al.  Letter by Puri et al Regarding Article, "Reductions in Atherogenic Lipids and Major Cardiovascular Events: A Pooled Analysis of 10 ODYSSEY Trials Comparing Alirocumab With Control". , 2017, Circulation.

[84]  E. Ohman,et al.  Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial , 2017, The Lancet.

[85]  G. Parati,et al.  Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10 – Should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials , 2017, Journal of hypertension.

[86]  C. Terkelsen,et al.  Clinical Use of Coronary CTA-Derived FFR for Decision-Making in Stable CAD. , 2017, JACC. Cardiovascular imaging.

[87]  S. Tsiodras,et al.  Influenza infection and heart failure—vaccination may change heart failure prognosis? , 2017, Heart Failure Reviews.

[88]  John P. Overington,et al.  PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease. , 2017, The Cochrane database of systematic reviews.

[89]  G. Cheon,et al.  Diagnostic Performance of Resting and Hyperemic Invasive Physiological Indices to Define Myocardial Ischemia: Validation With 13N-Ammonia Positron Emission Tomography. , 2017, JACC. Cardiovascular interventions.

[90]  D. Tousoulis,et al.  Effect of gender on the prognostic value of dobutamine stress myocardial contrast echocardiography. , 2017, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

[91]  Udo Hoffmann,et al.  Noninvasive FFR Derived From Coronary CT Angiography: Management and Outcomes in the PROMISE Trial. , 2017, JACC. Cardiovascular imaging.

[92]  M. Hlatky,et al.  Functional Testing or Coronary Computed Tomography Angiography in Patients With Stable Coronary Artery Disease. , 2017, Journal of the American College of Cardiology.

[93]  M. Pencina,et al.  Prognostic Value of Noninvasive Cardiovascular Testing in Patients With Stable Chest Pain: Insights From the PROMISE Trial (Prospective Multicenter Imaging Study for Evaluation of Chest Pain) , 2017, Circulation.

[94]  P. Jüni,et al.  Radial versus femoral access in patients with acute coronary syndromes with or without ST-segment elevation , 2017, European heart journal.

[95]  M. Wiese,et al.  Clinical Outcomes Associated with Medication Regimen Complexity in Older People: A Systematic Review , 2017, Journal of the American Geriatrics Society.

[96]  K. Farrington,et al.  Allopurinol as a therapeutic option in cardiovascular disease , 2017, Pharmacology & therapeutics.

[97]  W. Boden,et al.  Antianginal Therapy for Stable Ischemic Heart Disease , 2017, Journal of cardiovascular pharmacology and therapeutics.

[98]  M. Nyegaard,et al.  A GENETIC RISK SCORE PREDICTS CARDIOVASCULAR EVENTS IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE , 2017 .

[99]  A. Jeremias,et al.  Use of the Instantaneous Wave‐free Ratio or Fractional Flow Reserve in PCI , 2017, The New England journal of medicine.

[100]  E. Omerovic,et al.  Instantaneous Wave‐free Ratio versus Fractional Flow Reserve to Guide PCI , 2017, The New England journal of medicine.

[101]  Thomas M Maddox,et al.  ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, , 2017, Journal of the American College of Cardiology.

[102]  J. O’Keefe,et al.  Trending Cardiovascular Nutrition Controversies. , 2017, Journal of the American College of Cardiology.

[103]  O. Gerke,et al.  Diagnostic and prognostic value of a careful symptom evaluation and high sensitive troponin in patients with suspected stable angina pectoris without prior cardiovascular disease. , 2017, Atherosclerosis.

[104]  S. Cook,et al.  Stress cardiovascular magnetic resonance imaging: current and future perspectives , 2017, Expert review of cardiovascular therapy.

[105]  C. Loza Munárriz,et al.  Ranolazine for stable angina pectoris. , 2017, The Cochrane database of systematic reviews.

[106]  Jennifer G. Robinson,et al.  Safety of Very Low Low-Density Lipoprotein Cholesterol Levels With Alirocumab: Pooled Data From Randomized Trials. , 2017, Journal of the American College of Cardiology.

[107]  H. McGee,et al.  Exercise-based cardiac rehabilitation in twelve European countries results of the European cardiac rehabilitation registry. , 2017, International journal of cardiology.

[108]  D. Acosta,et al.  Relative clinical and economic impact of exercise echocardiography vs. exercise electrocardiography, as first line investigation in patients without known coronary artery disease and new stable angina: a randomized prospective study , 2017, European heart journal cardiovascular Imaging.

[109]  G. Guyatt,et al.  Electronic nicotine delivery systems and/or electronic non-nicotine delivery systems for tobacco smoking cessation or reduction: a systematic review and meta-analysis , 2017, BMJ Open.

[110]  K. Mahaffey,et al.  Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study–Renal (CANVAS‐R): A randomized, placebo‐controlled trial , 2017, Diabetes, obesity & metabolism.

[111]  U. Thadani,et al.  Drug Therapy for Stable Angina Pectoris , 2017, Drugs.

[112]  Simon Wandel,et al.  Renin angiotensin system inhibitors for patients with stable coronary artery disease without heart failure: systematic review and meta-analysis of randomized trials , 2017, British Medical Journal.

[113]  S. Bangalore,et al.  Management and outcomes of acute myocardial infarction in patients with chronic kidney disease. , 2017, International journal of cardiology.

[114]  P. Kirchhof,et al.  [2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS]. , 2016, Kardiologia polska.

[115]  Xueqi Li,et al.  Oral nicorandil reduces ischemic attacks in patients with stable angina: A prospective, multicenter, open-label, randomized, controlled study. , 2016, International journal of cardiology.

[116]  Patrizio Lancellotti,et al.  Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2016, European heart journal cardiovascular Imaging.

[117]  P. Jüni,et al.  A Prospective Natural History Study of Coronary Atherosclerosis Using Fractional Flow Reserve. , 2016, Journal of the American College of Cardiology.

[118]  P. Serruys,et al.  Long-term ticagrelor monotherapy versus standard dual antiplatelet therapy followed by aspirin monotherapy in patients undergoing biolimus-eluting stent implantation: rationale and design of the GLOBAL LEADERS trial. , 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[119]  G. Lip,et al.  Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI. , 2016, The New England journal of medicine.

[120]  J. Leipsic,et al.  SCCT guidelines for the performance and acquisition of coronary computed tomographic angiography: A report of the society of Cardiovascular Computed Tomography Guidelines Committee: Endorsed by the North American Society for Cardiovascular Imaging (NASCI). , 2016, Journal of cardiovascular computed tomography.

[121]  J. Rouleau,et al.  Ten-Year Outcomes After Coronary Artery Bypass Grafting According to Age in Patients With Heart Failure and Left Ventricular Systolic Dysfunction: An Analysis of the Extended Follow-Up of the STICH Trial (Surgical Treatment for Ischemic Heart Failure) , 2016, Circulation.

[122]  Min-Seon Kim,et al.  Long-Term Prognostic Value of Coronary CT Angiography in Asymptomatic Type 2 Diabetes Mellitus. , 2016, JACC. Cardiovascular imaging.

[123]  Deepak L. Bhatt,et al.  Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study , 2016, The Lancet.

[124]  G. Karthikeyan,et al.  Functional compared to anatomical imaging in the initial evaluation of patients with suspected coronary artery disease: An international, multi-center, randomized controlled trial (IAEA-SPECT/CTA study) , 2016, Journal of Nuclear Cardiology.

[125]  P. Doherty,et al.  The prognostic effect of cardiac rehabilitation in the era of acute revascularisation and statin therapy: A systematic review and meta-analysis of randomized and non-randomized studies – The Cardiac Rehabilitation Outcome Study (CROS) , 2016, European journal of preventive cardiology.

[126]  K. Park,et al.  Chronic Kidney Disease in the Second-Generation Drug-Eluting Stent Era: Pooled Analysis of the Korean Multicenter Drug-Eluting Stent Registry. , 2016, JACC. Cardiovascular interventions.

[127]  A. Stuck,et al.  Prognostic value of an abnormal response to acetylcholine in patients with angina and non-obstructive coronary artery disease: Long-term follow-up of the Heart Quest cohort. , 2016, International journal of cardiology.

[128]  R. Arbel,et al.  PCSK9 inhibitors may improve cardiovascular outcomes-Can we afford them? , 2016, International journal of cardiology.

[129]  C. McCarthy,et al.  The role of trimetazidine in cardiovascular disease: beyond an anti-anginal agent. , 2016, European heart journal. Cardiovascular pharmacotherapy.

[130]  R. Ferrence,et al.  Electronic Cigarettes for Smoking Cessation: A Systematic Review. , 2016, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[131]  C. Macintyre,et al.  Influenza vaccine as a coronary intervention for prevention of myocardial infarction , 2016, Heart.

[132]  Brian A Ference,et al.  Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis. , 2016, JAMA.

[133]  J. Singh,et al.  Allopurinol reduces the risk of myocardial infarction (MI) in the elderly: a study of Medicare claims , 2016, Arthritis Research & Therapy.

[134]  Amit Kiran,et al.  Influenza vaccination and risk of hospitalization in patients with heart failure: a self-controlled case series study , 2016, European heart journal.

[135]  G. Lip,et al.  2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines:  The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). , 2016, European heart journal.

[136]  U. Thadani.  Management of Stable Angina – Current Guidelines: A Critical Appraisal , 2016, Cardiovascular Drugs and Therapy.

[137]  S. Miyata,et al.  Beneficial effects of long-acting nifedipine on coronary vasomotion abnormalities after drug-eluting stent implantation: The NOVEL study. , 2016, European heart journal.

[138]  H. McRobbie,et al.  Electronic cigarettes for smoking cessation. , 2016, The Cochrane database of systematic reviews.

[139]  P. Avanzas,et al.  Beta-Blockers and Calcium Channel Blockers: First Line Agents , 2016, Cardiovascular Drugs and Therapy.

[140]  M. Roe,et al.  Predictors, Trends, and Outcomes (Among Older Patients ≥65 Years of Age) Associated With Beta-Blocker Use in Patients With Stable Angina Undergoing Elective Percutaneous Coronary Intervention: Insights From the NCDR Registry. , 2016, JACC. Cardiovascular interventions.

[141]  U. Olsson‐Strömberg,et al.  Cardiovascular Events Associated With Use of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Population-Based Cohort Study. , 2016, Annals of internal medicine.

[142]  Matthias Gutberlet,et al.  1-Year Outcomes of FFRCT-Guided Care in Patients With Suspected Coronary Disease: The PLATFORM Study. , 2016, Journal of the American College of Cardiology.

[143]  A. Yeung,et al.  Attenuated-Signal Plaque Progression Predicts Long-Term Mortality After Heart Transplantation: IVUS Assessment of Cardiac Allograft Vasculopathy. , 2016, Journal of the American College of Cardiology.

[144]  Volkmar Falk,et al.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016, Revista espanola de cardiologia.

[145]  Jane Nixon,et al.  Prognostic Value of Cardiovascular Magnetic Resonance and Single-Photon Emission Computed Tomography in Suspected Coronary Heart Disease: Long-Term Follow-up of a Prospective, Diagnostic Accuracy Cohort Study , 2016, Annals of Internal Medicine.

[146]  A. El-Menyar,et al.  Impact of Polypharmacy on Adherence to Evidence-Based Medication in Patients who Underwent Percutaneous Coronary Intervention. , 2016, Current vascular pharmacology.

[147]  Lenore J Launer,et al.  Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial. , 2016, JAMA.

[148]  J. Kaski,et al.  Vasodilator Therapy: Nitrates and Nicorandil , 2016, Cardiovascular Drugs and Therapy.

[149]  Deepak L. Bhatt,et al.  Reduction in Ischemic Events With Ticagrelor in Diabetic Patients With Prior Myocardial Infarction in PEGASUS-TIMI 54. , 2016, Journal of the American College of Cardiology.

[150]  Deepak L. Bhatt,et al.  Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease. , 2016, Journal of the American College of Cardiology.

[151]  S. Bangalore.  Stress testing in patients with chronic kidney disease: The need for ancillary markers for effective risk stratification and prognosis , 2016, Journal of Nuclear Cardiology.

[152]  J. Camm,et al.  Management of stable angina: A commentary on the European Society of Cardiology guidelines , 2016, European journal of preventive cardiology.

[153]  Kim Ekroos,et al.  Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol , 2016, European heart journal.

[154]  Akiko Maehara,et al.  Continuum of Vasodilator Stress From Rest to Contrast Medium to Adenosine Hyperemia for Fractional Flow Reserve Assessment. , 2016, JACC. Cardiovascular interventions.

[155]  E. V. van Beek,et al.  Use of Coronary Computed Tomographic Angiography to Guide Management of Patients With Coronary Disease , 2016, Journal of the American College of Cardiology.

[156]  K. Nieman,et al.  Calcium imaging and selective computed tomography angiography in comparison to functional testing for suspected coronary artery disease: the multicentre, randomized CRESCENT trial. , 2016, European heart journal.

[157]  Marc P. Bonaca,et al.  Ischaemic risk and efficacy of ticagrelor in relation to time from P2Y12 inhibitor withdrawal in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54. , 2016, European heart journal.

[158]  M. Perola,et al.  Genetic Risk Scores Predict Recurrence of Acute Coronary Syndrome , 2016, Circulation. Cardiovascular genetics.

[159]  A. Sardinha,et al.  Sexual Activity and Heart Patients: A Contemporary Perspective. , 2016, The Canadian journal of cardiology.

[160]  E. Shin,et al.  Anti-Anginal and Metabolic Effects of Carvedilol and Atenolol in Patients with Stable Angina Pectoris: A Prospective, Randomized, Parallel, Open-Label Study , 2016, American Journal of Cardiovascular Drugs.

[161]  J. M. Lee,et al.  Coronary Flow Reserve and Microcirculatory Resistance in Patients With Intermediate Coronary Stenosis. , 2016, Journal of the American College of Cardiology.

[162]  Marc P. Bonaca,et al.  Platelet Inhibition With Ticagrelor 60 mg Versus 90 mg Twice Daily in the PEGASUS-TIMI 54 Trial. , 2016, Journal of the American College of Cardiology.

[163]  S. Anderson,et al.  Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis , 2016, The Lancet.

[164]  G. Filardo,et al.  Excess short-term mortality in women after isolated coronary artery bypass graft surgery , 2016, Open Heart.

[165]  J. Kastrup,et al.  Coronary Microvascular Function and Cardiovascular Risk Factors in Women With Angina Pectoris and No Obstructive Coronary Artery Disease: The iPOWER Study , 2016, Journal of the American Heart Association.

[166]  S. Kapadia,et al.  Outcomes in Patients With Transcatheter Aortic Valve Replacement and Left Main Stenting: The TAVR-LM Registry. , 2016, Journal of the American College of Cardiology.

[167]  J. Spertus,et al.  Optimal medical therapy with or without percutaneous coronary intervention in women with stable coronary disease: A pre-specified subset analysis of the Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation (COURAGE) trial. , 2016, American heart journal.

[168]  J. Saw,et al.  Ticagrelor and aspirin for the prevention of cardiovascular events after coronary artery bypass graft surgery , 2016, Heart.

[169]  R. Senior,et al.  Novel techniques in stress echocardiography: a focus on the advantages and disadvantages , 2016, Expert review of cardiovascular therapy.

[170]  Oliver Lindner,et al.  Clinical use of quantitative cardiac perfusion PET: rationale, modalities and possible indications. Position paper of the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM) , 2016, European Journal of Nuclear Medicine and Molecular Imaging.

[171]  M. Karck,et al.  Female Gender and Differences in Outcome after Isolated Coronary Artery Bypass Graft Surgery: Does Age Play a Role? , 2016, PloS one.

[172]  S. Glantz,et al.  E-cigarettes and smoking cessation in real-world and clinical settings: a systematic review and meta-analysis. , 2016, The Lancet. Respiratory medicine.

[173]  J. Menke,et al.  Diagnostic accuracy and utility of coronary CT angiography with consideration of unevaluable results: A systematic review and multivariate Bayesian random-effects meta-analysis with intention to diagnose , 2016, European Radiology.

[174]  J. Prochaska,et al.  The Past, Present, and Future of Nicotine Addiction Therapy. , 2016, Annual review of medicine.

[175]  K. Alexander,et al.  Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial , 2016, The Lancet.

[176]  G. Weisz,et al.  Effects of Ranolazine on Angina and Quality of Life After Percutaneous Coronary Intervention With Incomplete Revascularization: Results From the Ranolazine for Incomplete Vessel Revascularization (RIVER-PCI) Trial , 2016, Circulation.

[177]  P. Serruys,et al.  Safety and Efficacy of New-Generation Drug-Eluting Stents in Women at High Risk for Atherothrombosis: From the Women in Innovation and Drug-Eluting Stents Collaborative Patient-Level Pooled Analysis , 2016, Circulation. Cardiovascular interventions.

[178]  Thalia Shoshana Field,et al.  Achieved Blood Pressure and Outcomes in the Secondary Prevention of Small Subcortical Strokes Trial , 2016, Hypertension.

[179]  A. Camm,et al.  Unresolved issues in the management of chronic stable angina. , 2015, International journal of cardiology.

[180]  M. Morice,et al.  Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk. , 2015, The New England journal of medicine.

[181]  Volker Klauss,et al.  Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised controlled trial , 2015, The Lancet.

[182]  S. Mehta,et al.  Radial versus femoral access for elderly patients with acute coronary syndrome undergoing coronary angiography and intervention: insights from the RIVAL trial. , 2015, American heart journal.

[183]  Hongliang Cong,et al.  Effect of High‐Dose Statin Pretreatment on the Incidence of Periprocedural Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention: Grading the Evidence Through a Cumulative Meta‐analysis , 2015, Clinical cardiology.

[184]  J. Catanese,et al.  Risk prediction by genetic risk scores for coronary heart disease is independent of self-reported family history , 2015, European heart journal.

[185]  R Jay Widmer,et al.  Prevalence of Coronary Microvascular Dysfunction Among Patients With Chest Pain and Nonobstructive Coronary Artery Disease. , 2015, JACC. Cardiovascular interventions.

[186]  E. Hannan,et al.  Revascularization in Patients With Multivessel Coronary Artery Disease and Chronic Kidney Disease: Everolimus-Eluting Stents Versus Coronary Artery Bypass Graft Surgery. , 2015, Journal of the American College of Cardiology.

[187]  B. Hesse,et al.  EANM procedural guidelines for radionuclide myocardial perfusion imaging with SPECT and SPECT/CT: 2015 revision , 2015, European Journal of Nuclear Medicine and Molecular Imaging.

[188]  E. Ohman,et al.  Pharmacological and emerging therapies in the treatment of chronic angina , 2015, The Lancet.

[189]  L. Køber,et al.  Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial , 2015, The Lancet.

[190]  Deepak L. Bhatt,et al.  Troponin and Cardiac Events in Stable Ischemic Heart Disease and Diabetes. , 2015, The New England journal of medicine.

[191]  N. Sattar,et al.  Prognostic significance of infarct core pathology revealed by quantitative non-contrast in comparison with contrast cardiac magnetic resonance imaging in reperfused ST-elevation myocardial infarction survivors , 2015, European heart journal.

[192]  F. Crea,et al.  International standardization of diagnostic criteria for vasospastic angina , 2015, European heart journal.

[193]  Twyla J. Hill,et al.  Change in sexual activity after a cardiac event: the role of medications, comorbidity, and psychosocial factors. , 2015, Applied nursing research : ANR.

[194]  D. Groves,et al.  Temporary sympathectomy in chronic refractory angina: a randomised, double-blind, placebo-controlled trial , 2015, British journal of pain.

[195]  A. Radjenovic,et al.  Assessment of Fractional Flow Reserve in Patients With Recent Non–ST-Segment–Elevation Myocardial Infarction: Comparative Study With 3-T Stress Perfusion Cardiac Magnetic Resonance Imaging , 2015, Circulation. Cardiovascular interventions.

[196]  D. Caldeira,et al.  [Analysis of the Cochrane Review: Influenza Vaccines for Preventing Cardiovascular Disease. Cochrane Database Syst Rev. 2015;5:CD005050]. , 2015, Acta medica portuguesa.

[197]  J. Critchley,et al.  Psychosocial interventions for smoking cessation in patients with coronary heart disease. , 2015, The Cochrane database of systematic reviews.

[198]  I. Savelieva,et al.  Relative efficacy of antianginal drugs used as add-on therapy in patients with stable angina: A systematic review and meta-analysis , 2015, European journal of preventive cardiology.

[199]  N. Peek,et al.  Cardiac rehabilitation and survival in a large representative community cohort of Dutch patients. , 2015, European heart journal.

[200]  Olle Melander,et al.  Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials , 2015, The Lancet.

[201]  S. Windecker,et al.  Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction. , 2015, Journal of the American College of Cardiology.

[202]  S. Solomon,et al.  Does influenza vaccination influence cardiovascular complications? , 2015, Expert review of cardiovascular therapy.

[203]  J. Furtado,et al.  Influenza vaccines for preventing cardiovascular disease , 2015, The Cochrane database of systematic reviews.

[204]  A. Jeremias,et al.  Prospective Assessment of the Diagnostic Accuracy of Instantaneous Wave-Free Ratio to Assess Coronary Stenosis Relevance: Results of ADVISE II International, Multicenter Study (ADenosine Vasodilator Independent Stenosis Evaluation II). , 2015, JACC. Cardiovascular interventions.

[205]  Antonio Colombo,et al.  Accuracy of intravascular ultrasound and optical coherence tomography in identifying functionally significant coronary stenosis according to vessel diameter: A meta-analysis of 2,581 patients and 2,807 lesions. , 2015, American heart journal.

[206]  M. Yacoub,et al.  Provocation of left ventricular outflow tract obstruction using nitrate inhalation in hypertrophic cardiomyopathy: Relation to electromechanical delay , 2015, Global cardiology science & practice.

[207]  Jennifer G. Robinson,et al.  Efficacy and safety of alirocumab in reducing lipids and cardiovascular events. , 2015, The New England journal of medicine.

[208]  Barry J. Davis,et al.  Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials , 2015, The Lancet.

[209]  D. Berman,et al.  Prognostic and Therapeutic Implications of Statin and Aspirin Therapy in Individuals With Nonobstructive Coronary Artery Disease: Results From the CONFIRM (Coronary CT Angiography Evaluation For Clinical Outcomes: An International Multicenter Registry) Registry , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[210]  Ryotaro Yamada,et al.  Invasive Evaluation of Patients With Angina in the Absence of Obstructive Coronary Artery Disease , 2015, Circulation.

[211]  T. Edvardsen,et al.  Sensitive cardiac troponins and N-terminal pro-B-type natriuretic peptide in stable coronary artery disease: correlation with left ventricular function as assessed by myocardial strain , 2015, The International Journal of Cardiovascular Imaging.

[212]  W. Gaissmaier,et al.  Cardiovascular risk factor distribution and subjective risk estimation in urban women – The BEFRI Study: a randomized cross-sectional study , 2015, BMC Medicine.

[213]  Tom R. Gaunt,et al.  Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts. , 2015, Circulation.

[214]  M. Budoff,et al.  Coronary Artery Calcium Screening: Does it Perform Better than Other Cardiovascular Risk Stratification Tools? , 2015, International journal of molecular sciences.

[215]  M. Sturek,et al.  Benefits of exercise training on coronary blood flow in coronary artery disease patients. , 2015, Progress in cardiovascular diseases.

[216]  K. Eagle,et al.  Acute coronary syndrome in young women under 55 years of age: clinical characteristics, treatment, and outcomes , 2015, Clinical Research in Cardiology.

[217]  R. Blankstein,et al.  Interaction of Impaired Coronary Flow Reserve and Cardiomyocyte Injury on Adverse Cardiovascular Outcomes in Patients Without Overt Coronary Artery Disease , 2015, Circulation.

[218]  E. Edelman,et al.  Efficacy of a device to narrow the coronary sinus in refractory angina. , 2015, The New England journal of medicine.

[219]  W. Weaver,et al.  Prasugrel Plus Aspirin Beyond 12 Months Is Associated With Improved Outcomes After Taxus Liberté Paclitaxel-Eluting Coronary Stent Placement , 2015, Circulation.

[220]  R. Blankstein,et al.  Global Coronary Flow Reserve Is Associated With Adverse Cardiovascular Events Independently of Luminal Angiographic Severity and Modifies the Effect of Early Revascularization , 2015, Circulation.

[221]  E. Nagel,et al.  Diagnostic Accuracy of Stress Myocardial Perfusion Imaging Compared to Invasive Coronary Angiography With Fractional Flow Reserve Meta-Analysis , 2015, Circulation. Cardiovascular imaging.

[222]  H. Kamel,et al.  Plaque Echolucency and Stroke Risk in Asymptomatic Carotid Stenosis: A Systematic Review and Meta-Analysis , 2015, Stroke.

[223]  Song Peng,et al.  The efficacy of trimetazidine on stable angina pectoris: a meta-analysis of randomized clinical trials. , 2014, International journal of cardiology.

[224]  G. Parati,et al.  Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials , 2014, Journal of hypertension.

[225]  Min Li,et al.  Diagnostic accuracy of myocardial magnetic resonance perfusion to diagnose ischemic stenosis with fractional flow reserve as reference: systematic review and meta-analysis. , 2014, JACC. Cardiovascular imaging.

[226]  A. Bank,et al.  Echocardiographic and clinical response to cardiac resynchronization therapy in heart failure patients with and without previous right ventricular pacing , 2014, European journal of heart failure.

[227]  William Wijns,et al.  Evolving concepts of angiogram: fractional flow reserve discordances in 4000 coronary stenoses. , 2014, European heart journal.

[228]  G. Rioufol,et al.  Prognostic value of fractional flow reserve: linking physiologic severity to clinical outcomes. , 2014, Journal of the American College of Cardiology.

[229]  V. Somers,et al.  The prognostic importance of weight loss in coronary artery disease: a systematic review and meta-analysis. , 2014, Mayo Clinic proceedings.

[230]  Deepak L. Bhatt,et al.  &bgr;-Blockers and Cardiovascular Events in Patients With and Without Myocardial Infarction: Post Hoc Analysis From the CHARISMA Trial , 2014, Circulation. Cardiovascular quality and outcomes.

[231]  Nikola Jagic,et al.  Fractional flow reserve-guided PCI for stable coronary artery disease. , 2014, The New England journal of medicine.

[232]  J. Tardif,et al.  Ivabradine in stable coronary artery disease without clinical heart failure. , 2014, The New England journal of medicine.

[233]  Akshay S. Desai,et al.  Angiotensin-neprilysin inhibition versus enalapril in heart failure. , 2014, The New England journal of medicine.

[234]  Seung‐Jung Park,et al.  Intravascular ultrasound-derived minimal lumen area criteria for functionally significant left main coronary artery stenosis. , 2014, JACC. Cardiovascular interventions.

[235]  F. Hu,et al.  Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: systematic review and dose-response meta-analysis of prospective cohort studies , 2014, BMJ : British Medical Journal.

[236]  W. Brenner,et al.  Myocardial CT Perfusion Imaging and SPECT for the Diagnosis of Coronary Artery Disease: A Head-to-Head Comparison from the CORE320 Multicenter Diagnostic Performance Study. , 2014, Radiology.

[237]  P. Kolh,et al.  Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis , 2014, BMJ : British Medical Journal.

[238]  W. Oetgen,et al.  Influenza and coronary artery disease: exploring a clinical association with myocardial infarction and analyzing the utility of vaccination in prevention of myocardial infarction. , 2014, Reviews in cardiovascular medicine.

[239]  T. Brown,et al.  Effect of sustaining lifestyle modifications (nonsmoking, weight reduction, physical activity, and mediterranean diet) after healing of myocardial infarction, percutaneous intervention, or coronary bypass (from the REasons for Geographic and Racial Differences in Stroke Study). , 2014, The American journal of cardiology.

[240]  K. Lohr,et al.  Transitional Care Interventions to Prevent Readmissions for Persons With Heart Failure , 2014, Annals of Internal Medicine.

[241]  D. Berman,et al.  Comparative definitions for moderate-severe ischemia in stress nuclear, echocardiography, and magnetic resonance imaging. , 2014, JACC. Cardiovascular imaging.

[242]  P. Damman,et al.  Physiological Basis and Long-Term Clinical Outcome of Discordance Between Fractional Flow Reserve and Coronary Flow Velocity Reserve in Coronary Stenoses of Intermediate Severity , 2014, Circulation. Cardiovascular interventions.

[243]  V. Perkovic,et al.  HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis , 2014, The Cochrane database of systematic reviews.

[244]  Petr Otahal,et al.  Prognostic implications of global LV dysfunction: a systematic review and meta-analysis of global longitudinal strain and ejection fraction , 2014, Heart.

[245]  S. Tobe,et al.  Contemporary use of β-blockers: clinical relevance of subclassification. , 2014, The Canadian journal of cardiology.

[246]  R. de Caterina,et al.  Angina pectoris and myocardial ischemia in the absence of obstructive coronary artery disease: practical considerations for diagnostic tests. , 2014, JACC. Cardiovascular interventions.

[247]  S. Solomon,et al.  Survival with cardiac-resynchronization therapy in mild heart failure. , 2014, The New England journal of medicine.

[248]  J. Kaski,et al.  Clinical Usefulness, Angiographic Characteristics, and Safety Evaluation of Intracoronary Acetylcholine Provocation Testing Among 921 Consecutive White Patients With Unobstructed Coronary Arteries , 2014, Circulation.

[249]  J. Tijssen,et al.  Increased hyperaemic coronary microvascular resistance adds to the presence of myocardial ischaemia. , 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[250]  V. Falk,et al.  Expert position paper on the management of antiplatelet therapy in patients undergoing coronary artery bypass graft surgery , 2014, European heart journal.

[251]  A. Jeremias,et al.  Multicenter core laboratory comparison of the instantaneous wave-free ratio and resting Pd/Pa with fractional flow reserve: the RESOLVE study. , 2014, Journal of the American College of Cardiology.

[252]  Hiroshi Ito,et al.  Diagnostic performance of noninvasive fractional flow reserve derived from coronary computed tomography angiography in suspected coronary artery disease: the NXT trial (Analysis of Coronary Blood Flow Using CT Angiography: Next Steps). , 2014, Journal of the American College of Cardiology.

[253]  B. Dimitrov,et al.  Does Routine Pressure Wire Assessment Influence Management Strategy at Coronary Angiography for Diagnosis of Chest Pain?: The RIPCORD Study , 2014, Circulation. Cardiovascular interventions.

[254]  Jeroen J. Bax,et al.  Risks and benefits of cardiac imaging: an analysis of risks related to imaging for coronary artery disease. , 2014, European heart journal.

[255]  D. Leung,et al.  Evaluation of coronary microvascular function by left ventricular contractile reserve with low-dose dobutamine echocardiography. , 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[256]  B. Whalley,et al.  Psychological Interventions for Coronary Heart Disease: Cochrane Systematic Review and Meta-analysis , 2014, International Journal of Behavioral Medicine.

[257]  C. Held,et al.  Biomarkers in Relation to the Effects of Ticagrelor in Comparison With Clopidogrel in Non–ST-Elevation Acute Coronary Syndrome Patients Managed With or Without In-Hospital Revascularization: A Substudy From the Prospective Randomized Platelet Inhibition and Patient Outcomes (PLATO) Trial , 2014, Circulation.

[258]  G. Rioufol,et al.  Outcome Impact of Coronary Revascularization Strategy Reclassification With Fractional Flow Reserve at Time of Diagnostic Angiography: Insights From a Large French Multicenter Fractional Flow Reserve Registry , 2014, Circulation.

[259]  Kristian Thorlund,et al.  Cardiovascular Events Associated With Smoking Cessation Pharmacotherapies: A Network Meta-Analysis , 2014, Circulation.

[260]  Spiros Denaxas,et al.  Prognostic models for stable coronary artery disease based on electronic health record cohort of 102 023 patients , 2013, European heart journal.

[261]  B. Ibáñez,et al.  Disturbed Coronary Hemodynamics in Vessels With Intermediate Stenoses Evaluated With Fractional Flow Reserve: A Combined Analysis of Epicardial and Microcirculatory Involvement in Ischemic Heart Disease , 2013, Circulation.

[262]  Daniel S Berman,et al.  Cardiac magnetic resonance imaging myocardial perfusion reserve index assessment in women with microvascular coronary dysfunction and reference controls. , 2013, Cardiovascular diagnosis and therapy.

[263]  Juliana de Lima Lopes,et al.  Cardiovascular changes resulting from sexual activity and sexual dysfunction after myocardial infarction: integrative review. , 2013, Journal of clinical nursing.

[264]  E. Antman,et al.  Edoxaban versus warfarin in patients with atrial fibrillation. , 2013, The New England journal of medicine.

[265]  G. Rosano,et al.  Effects of ranolazine in symptomatic patients with stable coronary artery disease. A systematic review and meta-analysis. , 2013, International journal of cardiology.

[266]  P. Peduzzi,et al.  Combined angiotensin inhibition for the treatment of diabetic nephropathy. , 2013, The New England journal of medicine.

[267]  S. Daskalopoulou,et al.  Sex differences in acute coronary syndrome symptom presentation in young patients. , 2013, JAMA internal medicine.

[268]  F. Fernández‐Avilés,et al.  Endothelial dysfunction over the course of coronary artery disease. , 2013, European heart journal.

[269]  B. Fridlund,et al.  Sexual counselling for individuals with cardiovascular disease and their partners: a consensus document from the American Heart Association and the ESC Council on Cardiovascular Nursing and Allied Professions (CCNAP). , 2013, European heart journal.

[270]  B. Phillips,et al.  Safety and Efficacy of Allopurinol in Chronic Kidney Disease , 2013, The Annals of pharmacotherapy.

[271]  Hassan Khan,et al.  Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences. , 2013, European heart journal.

[272]  Josef Coresh,et al.  Cystatin C versus creatinine in determining risk based on kidney function. , 2013, The New England journal of medicine.

[273]  A. Lucia,et al.  Exercise is the real polypill. , 2013, Physiology.

[274]  M. Gold,et al.  Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study. , 2013, European heart journal.

[275]  X. Y. Zhang,et al.  Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials , 2013, BDJ.

[276]  Christopher M. Kramer,et al.  Prognostic value of stress cardiac magnetic resonance imaging in patients with known or suspected coronary artery disease: a systematic review and meta-analysis. , 2013, Journal of the American College of Cardiology.

[277]  H. Tighiouart,et al.  Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis , 2013, Canadian Medical Association Journal.

[278]  T. Biering-Sørensen,et al.  Myocardial Strain Analysis by 2-Dimensional Speckle Tracking Echocardiography Improves Diagnostics of Coronary Artery Stenosis in Stable Angina Pectoris , 2013, Circulation. Cardiovascular imaging.

[279]  J. Svendsen,et al.  Strain echocardiography improves risk prediction of ventricular arrhythmias after myocardial infarction. , 2013, JACC. Cardiovascular imaging.

[280]  S. Maes,et al.  Lifestyle modification programmes for patients with coronary heart disease: a systematic review and meta-analysis of randomized controlled trials , 2013, European journal of preventive cardiology.

[281]  William T. Abraham,et al.  An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure , 2013, European heart journal.

[282]  A. Quyyumi,et al.  Aggregate risk score based on markers of inflammation, cell stress, and coagulation is an independent predictor of adverse cardiovascular outcomes. , 2013, Journal of the American College of Cardiology.

[283]  D. Berman,et al.  Impact of an automated multimodality point-of-order decision support tool on rates of appropriate testing and clinical decision making for individuals with suspected coronary artery disease: a prospective multicenter study. , 2013, Journal of the American College of Cardiology.

[284]  A. Soricelli,et al.  The Prognostic Value of Normal Stress Cardiac Magnetic Resonance in Patients With Known or Suspected Coronary Artery Disease: A Meta-analysis , 2013, Circulation. Cardiovascular imaging.

[285]  S. Redwood,et al.  ‘Warm-up Angina’: harnessing the benefits of exercise and myocardial ischaemia , 2013, Heart.

[286]  G. Lip,et al.  Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy. , 2013, European heart journal.

[287]  Peter Søgaard,et al.  Prediction of all-cause mortality and heart failure admissions from global left ventricular longitudinal strain in patients with acute myocardial infarction and preserved left ventricular ejection fraction. , 2013, Journal of the American College of Cardiology.

[288]  J. Spertus,et al.  Evaluation of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina: results from the TERISA randomized clinical trial (Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina). , 2013, Journal of the American College of Cardiology.

[289]  P. Mills,et al.  A Meta-Analysis of Mental Health Treatments and Cardiac Rehabilitation for Improving Clinical Outcomes and Depression Among Patients With Coronary Heart Disease , 2013, Psychosomatic medicine.

[290]  L. F. Waanders,et al.  Circulating Biomarkers for Predicting Cardiovascular Disease Risk; a Systematic Review and Comprehensive Overview of Meta-Analyses , 2013, PloS one.

[291]  C. Pepine,et al.  Calcium antagonists in the treatment of coronary artery disease. , 2013, Current opinion in pharmacology.

[292]  Tom Adriaenssens,et al.  Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial , 2013, The Lancet.

[293]  S. Solomon,et al.  Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease. , 2013, Journal of the American College of Cardiology.

[294]  T. Clarkson,et al.  Timing hypothesis for postmenopausal hormone therapy: its origin, current status, and future , 2013, Menopause.

[295]  N. Deshpande,et al.  Prasugrel versus clopidogrel for acute coronary syndromes without revascularization , 2013 .

[296]  P. Bagos,et al.  Percutaneous Coronary Intervention Versus Optimal Medical Therapy for Prevention of Spontaneous Myocardial Infarction in Subjects With Stable Ischemic Heart Disease , 2013, Circulation.

[297]  G. Chatellier,et al.  Diagnostic performance of computed tomography coronary angiography (from the Prospective National Multicenter Multivendor EVASCAN Study). , 2013, The American journal of cardiology.

[298]  F. Kronenberg,et al.  Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis , 2013, BMJ.

[299]  H. Shimokawa,et al.  Clinical implications of provocation tests for coronary artery spasm: safety, arrhythmic complications, and prognostic impact: multicentre registry study of the Japanese Coronary Spasm Association. , 2013, European heart journal.

[300]  M. Pencina,et al.  Prognostic value of stress myocardial perfusion positron emission tomography: results from a multicenter observational registry. , 2013, Journal of the American College of Cardiology.

[301]  D. Zipes,et al.  Spinal Cord Stimulation Therapy for Patients With Refractory Angina Who Are Not Candidates for Revascularization , 2012, Neuromodulation : journal of the International Neuromodulation Society.

[302]  G. Wells,et al.  Does rubidium-82 PET have superior accuracy to SPECT perfusion imaging for the diagnosis of obstructive coronary disease?: A systematic review and meta-analysis. , 2012, Journal of the American College of Cardiology.

[303]  R. Blankstein,et al.  Association Between Coronary Vascular Dysfunction and Cardiac Mortality in Patients With and Without Diabetes Mellitus , 2012, Circulation.

[304]  T. Edvardsen,et al.  Duration of myocardial early systolic lengthening predicts the presence of significant coronary artery disease. , 2012, Journal of the American College of Cardiology.

[305]  Nikola Jagic,et al.  Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. , 2012, The New England journal of medicine.

[306]  A. Donato,et al.  Predictive accuracy of ST depression during rapid atrial fibrillation on the presence of obstructive coronary artery disease. , 2012, The American journal of emergency medicine.

[307]  D. Goff,et al.  Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. , 2012, JAMA.

[308]  Giel Nijpels,et al.  Common carotid intima-media thickness measurements in cardiovascular risk prediction: a meta-analysis. , 2012, JAMA.

[309]  Michael Fiechter,et al.  Diagnostic Value of 13N-Ammonia Myocardial Perfusion PET: Added Value of Myocardial Flow Reserve , 2012, The Journal of Nuclear Medicine.

[310]  S. Bangalore,et al.  Percutaneous Coronary Intervention Versus Optimal Medical Therapy in Stable Coronary Artery Disease: A Systematic Review and Meta-Analysis of Randomized Clinical Trials , 2012, Circulation. Cardiovascular interventions.

[311]  S. Windecker,et al.  SPIRIT Women, evaluation of the safety and efficacy of the XIENCE V everolimus-eluting stent system in female patients: referral time for coronary intervention and 2-year clinical outcomes. , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[312]  D. Berman,et al.  Prognosis in the era of comparative effectiveness research: Where is nuclear cardiology now and where should it be? , 2012, Journal of Nuclear Cardiology.

[313]  Filippo Cademartiri,et al.  Prediction model to estimate presence of coronary artery disease: retrospective pooled analysis of existing cohorts , 2012, BMJ : British Medical Journal.

[314]  Filippo Cademartiri,et al.  Prediction model to estimate presence of coronary artery disease: retrospective pooled analysis of existing cohorts , 2012, BMJ : British Medical Journal.

[315]  J. Daubert,et al.  Long‐term mortality with cardiac resynchronization therapy in the Cardiac Resynchronization‐Heart Failure (CARE‐HF) trial , 2012, European journal of heart failure.

[316]  E. Nagel,et al.  Diagnostic performance of noninvasive myocardial perfusion imaging using single-photon emission computed tomography, cardiac magnetic resonance, and positron emission tomography imaging for the detection of obstructive coronary artery disease: a meta-analysis. , 2012, Journal of the American College of Cardiology.

[317]  Ran Klein,et al.  Does quantification of myocardial flow reserve using rubidium-82 positron emission tomography facilitate detection of multivessel coronary artery disease? , 2012, Journal of Nuclear Cardiology.

[318]  J. Ioannidis,et al.  Minimal and null predictive effects for the most popular blood biomarkers of cardiovascular disease. , 2012, Circulation research.

[319]  Erik Jørgensen,et al.  Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. , 2012, European heart journal.

[320]  David L. Brown,et al.  Initial coronary stent implantation with medical therapy vs medical therapy alone for stable coronary artery disease: meta-analysis of randomized controlled trials. , 2012, Archives of internal medicine.

[321]  C. J. Malkin,et al.  The impact of increased age on outcome from a strategy of early invasive management and revascularisation in patients with acute coronary syndromes: retrospective analysis study from the ACACIA registry , 2012, BMJ Open.

[322]  J. Jensen,et al.  Risk stratification of patients suspected of coronary artery disease: comparison of five different models. , 2012, Atherosclerosis.

[323]  Jeroen J. Bax,et al.  2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). , 2011, European heart journal.

[324]  C. Cannon,et al.  Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomes. , 2011, European heart journal.

[325]  D. Berman,et al.  Prevalence and severity of coronary artery disease and adverse events among symptomatic patients with coronary artery calcification scores of zero undergoing coronary computed tomography angiography: results from the CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International , 2011, Journal of the American College of Cardiology.

[326]  M. Pencina,et al.  Improved Cardiac Risk Assessment With Noninvasive Measures of Coronary Flow Reserve , 2011, Circulation.

[327]  H. Khalil.  Psychological and pharmacological interventions for depression in patients with coronary artery disease , 2011 .

[328]  Richard D. White,et al.  Prognostic Value of Routine Cardiac Magnetic Resonance Assessment of Left Ventricular Ejection Fraction and Myocardial Damage: An International, Multicenter Study , 2011, Circulation. Cardiovascular imaging.

[329]  Mika Teräs,et al.  Clinical Value of Absolute Quantification of Myocardial Perfusion With 15O-Water in Coronary Artery Disease , 2011, Circulation. Cardiovascular imaging.

[330]  K. Smith,et al.  In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the National Heart, Lung and Blood Institute Women's Ischemia , 2011, American heart journal.

[331]  L. Shaw,et al.  Comparative Effectiveness of Exercise Electrocardiography With or Without Myocardial Perfusion Single Photon Emission Computed Tomography in Women With Suspected Coronary Artery Disease: Results From the What Is the Optimal Method for Ischemia Evaluation in Women (WOMEN) Trial , 2011, Circulation.

[332]  P. Gurbel,et al.  Earlier recovery of platelet function after discontinuation of treatment with ticagrelor compared with clopidogrel in patients with high antiplatelet responses , 2011, Journal of thrombosis and haemostasis : JTH.

[333]  P. Lamendola,et al.  [Coronary microvascular dysfunction. An update]. , 2011, Recenti progressi in medicina.

[334]  F. Blackstock,et al.  Psychoeducational Rehabilitation for Health Behavior Change in Coronary Artery Disease: A SYSTEMATIC REVIEW OF CONTROLLED TRIALS , 2011, Journal of cardiopulmonary rehabilitation and prevention.

[335]  Deepak L. Bhatt,et al.  Apixaban with antiplatelet therapy after acute coronary syndrome. , 2011, The New England journal of medicine.

[336]  Mouaz Al-Mallah,et al.  Age- and sex-related differences in all-cause mortality risk based on coronary computed tomography angiography findings results from the International Multicenter CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry) of 23,854 patients without know , 2011, Journal of the American College of Cardiology.

[337]  B. Chow,et al.  Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia. , 2011, Journal of the American College of Cardiology.

[338]  L. Shaw,et al.  Comparison of Framingham, PROCAM, SCORE, and Diamond Forrester to predict coronary atherosclerosis and cardiovascular events , 2011, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[339]  S. Ebrahim,et al.  Exercise-based cardiac rehabilitation for coronary heart disease. , 2011, The Cochrane database of systematic reviews.

[340]  Hatem Alkadhi,et al.  A clinical prediction rule for the diagnosis of coronary artery disease: validation, updating, and extension. , 2011, European heart journal.

[341]  L. Husmann,et al.  Prognostic value of cardiac hybrid imaging integrating single-photon emission computed tomography with coronary computed tomography angiography. , 2011, European heart journal.

[342]  J. Lacalle,et al.  Transmyocardial laser revascularization versus medical therapy for refractory angina , 2011, The Cochrane database of systematic reviews.

[343]  R. Hachamovitch,et al.  Incremental Prognostic Significance of Combined Cardiac Magnetic Resonance Imaging, Adenosine Stress Perfusion, Delayed Enhancement, and Left Ventricular Function Over Preimaging Information for the Prediction of Adverse Events , 2011, Circulation.

[344]  William L. Haskell,et al.  Cardiorespiratory Fitness and Classification of Risk of Cardiovascular Disease Mortality , 2011, Circulation.

[345]  Guido Germano,et al.  Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy. , 2011, European heart journal.

[346]  Victor Mor-Avi,et al.  Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography. , 2011, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[347]  Akiko Maehara,et al.  A prospective natural-history study of coronary atherosclerosis. , 2011, The New England journal of medicine.

[348]  J. McMurray,et al.  Eplerenone in patients with systolic heart failure and mild symptoms. , 2011, The New England journal of medicine.

[349]  Taixiang Wu,et al.  Nitrates for stable angina: a systematic review and meta-analysis of randomized clinical trials. , 2011, International journal of cardiology.

[350]  A. Khera,et al.  Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. , 2010, JAMA.

[351]  Rosanna Abbate,et al.  Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis. , 2010, The American journal of clinical nutrition.

[352]  C. Cannon,et al.  Inhibitory effects of ticagrelor compared with clopidogrel on platelet function in patients with acute coronary syndromes: the PLATO (PLATelet inhibition and patient Outcomes) PLATELET substudy. , 2010, Journal of the American College of Cardiology.

[353]  Jeroen J. Bax,et al.  Relationship between obstructive coronary artery disease and abnormal stress testing in patients with paroxysmal or persistent atrial fibrillation , 2010, The International Journal of Cardiovascular Imaging.

[354]  Michael Böhm,et al.  Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study , 2010, The Lancet.

[355]  A. Becker,et al.  Ruling out coronary artery disease in primary care: development and validation of a simple prediction rule , 2010, Canadian Medical Association Journal.

[356]  P. Gurbel,et al.  Incidence of dyspnea and assessment of cardiac and pulmonary function in patients with stable coronary artery disease receiving ticagrelor, clopidogrel, or placebo in the ONSET/OFFSET study. , 2010, Journal of the American College of Cardiology.

[357]  B. Nossaman,et al.  Nitrates and Nitrites in the Treatment of Ischemic Cardiac Disease , 2010, Cardiology in review.

[358]  Sanjay Kaul,et al.  Low diagnostic yield of elective coronary angiography. , 2010, The New England journal of medicine.

[359]  J. Danesh,et al.  Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies , 2010, The Lancet.

[360]  Carl J Pepine,et al.  Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study. , 2010, Journal of the American College of Cardiology.

[361]  C. Lang,et al.  Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial , 2010, The Lancet.

[362]  M. Schellings,et al.  The Extent of Coronary Atherosclerosis Is Associated With Increasing Circulating Levels of High Sensitive Cardiac Troponin T , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[363]  Keith R. Abrams,et al.  Evaluating the Quality of Research into a Single Prognostic Biomarker: A Systematic Review and Meta-analysis of 83 Studies of C-Reactive Protein in Stable Coronary Artery Disease , 2010, PLoS medicine.

[364]  S. Umemura,et al.  Digital assessment of endothelial function and ischemic heart disease in women. , 2010, Journal of the American College of Cardiology.

[365]  H. Gurm,et al.  Gender differences in adverse outcomes after contemporary percutaneous coronary intervention: an analysis from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) percutaneous coronary intervention registry. , 2010, American heart journal.

[366]  D. Waters,et al.  Usefulness of heart rate at rest as a predictor of mortality, hospitalization for heart failure, myocardial infarction, and stroke in patients with stable coronary heart disease (Data from the Treating to New Targets [TNT] trial). , 2010, The American journal of cardiology.

[367]  D. Berman,et al.  Intensive multifactorial intervention for stable coronary artery disease: optimal medical therapy in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial. , 2010, Journal of the American College of Cardiology.

[368]  T. Edvardsen,et al.  Strain Echocardiography and Wall Motion Score Index Predicts Final Infarct Size in Patients With Non–ST-Segment–Elevation Myocardial Infarction , 2010, Circulation. Cardiovascular imaging.

[369]  S. Yusuf,et al.  Association of Diet, Exercise, and Smoking Modification With Risk of Early Cardiovascular Events After Acute Coronary Syndromes , 2010, Circulation.

[370]  U. Siebert,et al.  Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. , 2009, The New England journal of medicine.

[371]  Wojciech Zareba,et al.  Cardiac-resynchronization therapy for the prevention of heart-failure events. , 2009, The New England journal of medicine.

[372]  Tobias Reichlin,et al.  Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. , 2009, The New England journal of medicine.

[373]  C. Noel Bairey Merz,et al.  Women and ischemic heart disease: evolving knowledge. , 2009, Journal of the American College of Cardiology.

[374]  R. Kwong,et al.  Complementary Prognostic Values of Stress Myocardial Perfusion and Late Gadolinium Enhancement Imaging by Cardiac Magnetic Resonance in Patients With Known or Suspected Coronary Artery Disease , 2009, Circulation.

[375]  R. Ferrari,et al.  Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial. , 2009, European heart journal.

[376]  R. Siegel,et al.  Meta-analysis of prognostic value of stress testing in patients with asymptomatic severe aortic stenosis. , 2009, The American journal of cardiology.

[377]  D. Symmons,et al.  EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis , 2009, Annals of the rheumatic diseases.

[378]  Claes Held,et al.  Ticagrelor versus clopidogrel in patients with acute coronary syndromes. , 2009, The New England journal of medicine.

[379]  Thomas H. Marwick,et al.  Prediction of All-Cause Mortality From Global Longitudinal Speckle Strain: Comparison With Ejection Fraction and Wall Motion Scoring , 2009, Circulation. Cardiovascular imaging.

[380]  Oliver Gaemperli,et al.  Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve. , 2009, Journal of the American College of Cardiology.

[381]  E. Banks,et al.  Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis. , 2009, American journal of epidemiology.

[382]  Regina M. Hardison,et al.  A randomized trial of therapies for type 2 diabetes and coronary artery disease. , 2009, The New England journal of medicine.

[383]  A. Pereira,et al.  Mild chronic kidney dysfunction and treatment strategies for stable coronary artery disease. , 2009, The Journal of thoracic and cardiovascular surgery.

[384]  R. Collins,et al.  Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials , 2009, The Lancet.

[385]  M. Law,et al.  Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies , 2009, BMJ : British Medical Journal.

[386]  Victor Mor-Avi,et al.  Comparative diagnostic accuracy of multiplane and multislice three-dimensional dobutamine stress echocardiography in the diagnosis of coronary artery disease. , 2009, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[387]  E. Braunwald,et al.  Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes) 36 Trial. , 2009, Journal of the American College of Cardiology.

[388]  Jörg Hausleiter,et al.  Prognostic value of coronary computed tomographic angiography for prediction of cardiac events in patients with suspected coronary artery disease. , 2009, JACC. Cardiovascular imaging.

[389]  Thomas A Trikalinos,et al.  Percutaneous coronary interventions for non-acute coronary artery disease: a quantitative 20-year synopsis and a network meta-analysis , 2009, The Lancet.

[390]  E. Picano,et al.  Additive prognostic value of coronary flow reserve in patients with chest pain syndrome and normal or near-normal coronary arteries. , 2009, The American journal of cardiology.

[391]  W. Hundley,et al.  Dobutamine cardiac magnetic resonance results predict cardiac prognosis in women with known or suspected ischemic heart disease. , 2009, JACC. Cardiovascular imaging.

[392]  F. Veglia,et al.  Contrast Volume During Primary Percutaneous Coronary Intervention and Subsequent Contrast-Induced Nephropathy and Mortality , 2009, Annals of Internal Medicine.

[393]  G. Teule,et al.  Association between anxiety disorder and the extent of ischemia observed in cardiac syndrome X , 2009, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[394]  D. Berman,et al.  Threshold, incidence, and predictors of prognostically high-risk silent ischemia in asymptomatic patients without prior diagnosis of coronary artery disease , 2009, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[395]  M. Gold,et al.  Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. , 2008, Journal of the American College of Cardiology.

[396]  David R. Williams,et al.  Mental disorders among persons with heart disease - results from World Mental Health surveys. , 2008, General hospital psychiatry.

[397]  Jens-Uwe Voigt,et al.  Stress Echocardiography Expert Consensus Statement--Executive Summary: European Association of Echocardiography (EAE) (a registered branch of the ESC). , 2008, European heart journal.

[398]  L. Tavazzi,et al.  Global secondary prevention strategies to limit event recurrence after myocardial infarction: results of the GOSPEL study, a multicenter, randomized controlled trial from the Italian Cardiac Rehabilitation Network. , 2008, Archives of internal medicine.

[399]  K. Airaksinen,et al.  Trimetazidine, a Metabolic Modulator, Has Cardiac and Extracardiac Benefits in Idiopathic Dilated Cardiomyopathy , 2008, Circulation.

[400]  V. Menon,et al.  Enrollment of women in National Heart, Lung, and Blood Institute-funded cardiovascular randomized controlled trials fails to meet current federal mandates for inclusion. , 2008, Journal of the American College of Cardiology.

[401]  S. Keteyian,et al.  Peak aerobic capacity predicts prognosis in patients with coronary heart disease. , 2008, American heart journal.

[402]  R. Kim,et al.  Value of cardiovascular magnetic resonance stress perfusion testing for the detection of coronary artery disease in women. , 2008, JACC. Cardiovascular imaging.

[403]  O. Faergeman,et al.  Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial , 2008, The Lancet.

[404]  R. Haynes,et al.  Interventions for enhancing medication adherence. , 2008, The Cochrane database of systematic reviews.

[405]  S. Yusuf,et al.  Telmisartan, ramipril, or both in patients at high risk for vascular events. , 2008, The New England journal of medicine.

[406]  William A Zoghbi,et al.  A randomized cross-over study for evaluation of the effect of image optimization with contrast on the diagnostic accuracy of dobutamine echocardiography in coronary artery disease The OPTIMIZE Trial. , 2008, JACC. Cardiovascular imaging.

[407]  C. Polanczyk,et al.  Association of anemia with clinical outcomes in stable coronary artery disease , 2008, Coronary artery disease.

[408]  C. Pepine,et al.  Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the INternational VErapamil-SR/trandolapril STudy (INVEST). , 2007, European heart journal.

[409]  R. Boellaard,et al.  Microvascular Function in Viable Myocardium After Chronic Infarction Does Not Influence Fractional Flow Reserve Measurements , 2007, Journal of Nuclear Medicine.

[410]  Leon Axel,et al.  Is subendocardial ischaemia present in patients with chest pain and normal coronary angiograms? A cardiovascular MR study. , 2007, European heart journal.

[411]  Michael R Gold,et al.  Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study. , 2007, Journal of the American College of Cardiology.

[412]  Anushka Patel,et al.  Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial , 2007, The Lancet.

[413]  J. Danesh,et al.  Renal Function and Risk of Coronary Heart Disease in General Populations: New Prospective Study and Systematic Review , 2007, PLoS medicine.

[414]  M. Hunink,et al.  Stress echocardiography, stress single-photon-emission computed tomography and electron beam computed tomography for the assessment of coronary artery disease: a meta-analysis of diagnostic performance. , 2007, American heart journal.

[415]  Zhan-quan Li,et al.  Double-blind, multicenter, active-controlled, randomized clinical trial to assess the safety and efficacy of orally administered nicorandil in patients with stable angina pectoris in China. , 2007, Circulation journal : official journal of the Japanese Circulation Society.

[416]  A. Skene,et al.  Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial. , 2007, JAMA.

[417]  A. Støylen,et al.  Automated analysis of myocardial deformation at dobutamine stress echocardiography: an angiographic validation. , 2007, Journal of the American College of Cardiology.

[418]  D. Berman,et al.  Optimal medical therapy with or without PCI for stable coronary disease. , 2007, The New England journal of medicine.

[419]  Sebastian Kelle,et al.  Prognostic Value of Cardiac Magnetic Resonance Stress Tests: Adenosine Stress Perfusion and Dobutamine Stress Wall Motion Imaging , 2007, Circulation.

[420]  M. Matheny,et al.  A propensity analysis of the risk of vascular complications after cardiac catheterization procedures with the use of vascular closure devices. , 2007, American heart journal.

[421]  H. Bartelink,et al.  Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. , 2007, Journal of the National Cancer Institute.

[422]  R. Redberg,et al.  The prognostic value of normal exercise myocardial perfusion imaging and exercise echocardiography: a meta-analysis. , 2007, Journal of the American College of Cardiology.

[423]  L. Shaw,et al.  An initial strategy of intensive medical therapy is comparable to that of coronary revascularization for suppression of scintigraphic ischemia in high-risk but stable survivors of acute myocardial infarction. , 2006, Journal of the American College of Cardiology.

[424]  Krishnaswamy Chandrasekaran,et al.  Role of biplane and biplane echocardiographically guided 3-dimensional echocardiography during dobutamine stress echocardiography. , 2006, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[425]  S. Yusuf,et al.  Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials , 2006, The Lancet.

[426]  L. Rydén,et al.  Oral glucose tolerance test is needed for appropriate classification of glucose regulation in patients with coronary artery disease: a report from the Euro Heart Survey on Diabetes and the Heart , 2006, Heart.

[427]  Nick Freemantle,et al.  Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]. , 2006, European heart journal.

[428]  Jean-Claude Tardif,et al.  Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina. , 2005, European heart journal.

[429]  D. Berman,et al.  Prognostic significance of dyspnea in patients referred for cardiac stress testing. , 2005, The New England journal of medicine.

[430]  R. Collins,et al.  Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins , 2005, The Lancet.

[431]  Morton F Arnsdorf,et al.  The prognostic value of a nomogram for exercise capacity in women. , 2005, The New England journal of medicine.

[432]  Jean-Claude Tardif,et al.  Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. , 2005, European heart journal.

[433]  L. Ried,et al.  A Study of Antihypertensive Drugs and Depressive Symptoms (SADD-Sx) in Patients Treated With a Calcium Antagonist Versus an Atenolol Hypertension Treatment Strategy in the International Verapamil SR-Trandolapril Study (INVEST) , 2005, Psychosomatic medicine.

[434]  Akshay S. Desai,et al.  Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials. , 2005, JAMA.

[435]  A. Cohen-Solal,et al.  Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). , 2005, European heart journal.

[436]  R. Bugiardini,et al.  Angina with "normal" coronary arteries: a changing philosophy. , 2005, JAMA.

[437]  Randall C. Thompson,et al.  Predictors of Quality-of-Life Benefit After Percutaneous Coronary Intervention , 2004, Circulation.

[438]  Eric Fain,et al.  Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. , 2004, The New England journal of medicine.

[439]  Ralph D'Agostino,et al.  Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. , 2004, The New England journal of medicine.

[440]  F. Creed,et al.  Distinct psychosocial differences between women with coronary heart disease and cardiac syndrome X. , 2004, European heart journal.

[441]  J. McMurray,et al.  Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials. , 2004, Journal of the American College of Cardiology.

[442]  S. Kernis,et al.  Does beta-blocker therapy improve clinical outcomes of acute myocardial infarction after successful primary angioplasty? , 2004, Journal of the American College of Cardiology.

[443]  Haya R Rubin,et al.  Comprehensive discharge planning with postdischarge support for older patients with congestive heart failure: a meta-analysis. , 2004, JAMA.

[444]  Carl J Pepine,et al.  A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial. , 2003, JAMA.

[445]  A. Kadish,et al.  DEFibrillators In Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE). , 2003, Cardiac electrophysiology review.

[446]  C. Tuxen,et al.  Prevalence of impaired left ventricular systolic function and heart failure in a middle aged and elderly urban population segment of Copenhagen , 2003, Heart.

[447]  L. Monti,et al.  Short- and long-term beneficial effects of trimetazidine in patients with diabetes and ischemic cardiomyopathy. , 2003, American heart journal.

[448]  C. Nemeroff,et al.  Epidemiology of comorbid coronary artery disease and depression , 2003, Biological Psychiatry.

[449]  J. Rouleau,et al.  Neurohormones and oxidative stress in nonischemic cardiomyopathy: relationship to survival and the effect of treatment with amlodipine. , 2003, American heart journal.

[450]  J. Critchley,et al.  Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. , 2003, JAMA.

[451]  G. Perna,et al.  Exercise-induced myocardial ischaemia detected by cardiopulmonary exercise testing. , 2003, European heart journal.

[452]  D. Berman,et al.  Comparison of the Short‐Term Survival Benefit Associated With Revascularization Compared With Medical Therapy in Patients With No Prior Coronary Artery Disease Undergoing Stress Myocardial Perfusion Single Photon Emission Computed Tomography , 2003, Circulation.

[453]  Larry Scherwitz,et al.  Improvement in medical risk factors and quality of life in women and men with coronary artery disease in the Multicenter Lifestyle Demonstration Project. , 2003, The American journal of cardiology.

[454]  Jeroen J. Bax,et al.  Noninvasive evaluation of ischaemic heart disease: myocardial perfusion imaging or stress echocardiography? , 2003, European heart journal.

[455]  M. Gheorghiade,et al.  The Role of Echocardiography in the Diagnosis and Management of Heart Failure , 2003, Heart Failure Reviews.

[456]  Eckart Fleck,et al.  Safety and feasibility of high-dose dobutamine-atropine stress cardiovascular magnetic resonance for diagnosis of myocardial ischaemia: experience in 1000 consecutive cases. , 2003, European heart journal.

[457]  D. Murdoch,et al.  The value of routine non-invasive tests to predict clinical outcome in stable angina. , 2003, European heart journal.

[458]  P. Hall,et al.  Mortality from cardiovascular disease more than 10 years after radiotherapy for breast cancer: nationwide cohort study of 90 000 Swedish women , 2003, BMJ : British Medical Journal.

[459]  L. Tavazzi,et al.  Efficacy of monotherapy compared with combined antianginal drugs in the treatment of chronic stable angina pectoris: a meta-analysis , 2002, Coronary artery disease.

[460]  D. DeMets,et al.  Effect of Carvedilol on the Morbidity of Patients With Severe Chronic Heart Failure: Results of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study , 2002, Circulation.

[461]  H. Arnesen,et al.  Warfarin, aspirin, or both after myocardial infarction. , 2002, The New England journal of medicine.

[462]  W. Hillis,et al.  Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial , 2002, The Lancet.

[463]  Lucas M Bachmann,et al.  Communicating accuracy of tests to general practitioners: a controlled study , 2002, BMJ : British Medical Journal.

[464]  Victor F. Froelicher,et al.  Exercise capacity and mortality among men referred for exercise testing. , 2002, The New England journal of medicine.

[465]  M. Cucherat,et al.  Bisoprolol for the treatment of chronic heart failure: a meta-analysis on individual data of two placebo-controlled studies--CIBIS and CIBIS II. Cardiac Insufficiency Bisoprolol Study. , 2002, American heart journal.

[466]  P. Poole‐Wilson,et al.  Current evidence supporting the role of diuretics in heart failure: a meta analysis of randomised controlled trials. , 2002, International journal of cardiology.

[467]  A. Mattioli,et al.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.

[468]  Susan A. Keller,et al.  Effects of Enhanced External Counterpulsation on Health-Related Quality of Life Continue 12 Months After Treatment: A Substudy of the Multicenter Study of Enhanced External Counterpulsation , 2002, Journal of Investigative Medicine.

[469]  T. Marwick,et al.  Prediction of Mortality by Exercise Echocardiography: A Strategy for Combination With the Duke Treadmill Score , 2001, Circulation.

[470]  H. Dargie,et al.  Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial , 2001, The Lancet.

[471]  J. Daubert,et al.  Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. , 2001, The New England journal of medicine.

[472]  S. Connolly,et al.  Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study. , 2000, European heart journal.

[473]  O. Simonetti,et al.  The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. , 2000, The New England journal of medicine.

[474]  I. Ringqvist,et al.  Monotherapy with amlodipine or atenolol versus their combination in stable angina pectoris , 2000, Clinical cardiology.

[475]  R. Cappato,et al.  Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH). , 2000, Circulation.

[476]  D. Webb,et al.  Sildenafil citrate potentiates the hypotensive effects of nitric oxide donor drugs in male patients with stable angina. , 2000, Journal of the American College of Cardiology.

[477]  B. Pitt,et al.  The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure , 2000 .

[478]  Salim Yusuf,et al.  Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients , 2000, The Lancet.

[479]  K. McDonald,et al.  Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina. , 2000, JAMA.

[480]  M Gent,et al.  Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone. , 2000, Circulation.

[481]  John Wikstrand,et al.  Effects of Controlled-Release Metoprolol on Total Mortality, Hospitalizations, and Well-being in Patients with Heart Failure: The Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF) , 2000 .

[482]  B. Pitt,et al.  The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. , 1999, The New England journal of medicine.

[483]  Fach,et al.  Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF) , 1999, The Lancet.

[484]  C. Pater,et al.  Antianginal efficacy of the combination of felodipine-metoprolol 10/100 mg compared with each drug alone in patients with stable effort-induced angina pectoris: a multicenter parallel group study. The TRAFFIC Study Group. , 1999, American heart journal.

[485]  S. Homma,et al.  Feasibility of real-time 3-dimensional treadmill stress echocardiography. , 1999, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[486]  P. Stone,et al.  Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris. , 1999, The American journal of cardiology.

[487]  S. Stewart,et al.  Prolonged beneficial effects of a home-based intervention on unplanned readmissions and mortality among patients with congestive heart failure. , 1999, Archives of internal medicine.

[488]  CIBIS-II Investigators and Committees.  The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial , 1999, The Lancet.

[489]  C. Dennis,et al.  The Electrocardiographic Exercise Test in a Population with Reduced Workup Bias: Diagnostic Performance, Computerized Interpretation, and Multivariable Prediction , 1998, Annals of Internal Medicine.

[490]  C. Held,et al.  Ischaemia during exercise and ambulatory monitoring in patients with stable angina pectoris and healthy controls. Gender differences and relationships to catecholamines. , 1998, European heart journal.

[491]  P. Stone,et al.  Prognostic significance of myocardial ischemia detected by ambulatory electrocardiography, exercise treadmill testing, and electrocardiogram at rest to predict cardiac events by one year (the Asymptomatic Cardiac Ischemia Pilot [ACIP] study) , 1997, The American journal of cardiology.

[492]  M. Keller,et al.  A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. , 1997, The New England journal of medicine.

[493]  M. Lauer,et al.  Use of exercise echocardiography for prognostic evaluation of patients with known or suspected coronary artery disease. , 1997, Journal of the American College of Cardiology.

[494]  N. Geller,et al.  Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization. , 1997, Circulation.

[495]  David Schultz,et al.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) , 1996, The Lancet.

[496]  C M O'Connor,et al.  Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group. , 1996, The New England journal of medicine.

[497]  P. H. van der Voort,et al.  Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. , 1996, The New England journal of medicine.

[498]  J. Cohn,et al.  The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. , 1996, The New England journal of medicine.

[499]  P. Whelton,et al.  Blood pressure and end-stage renal disease in men. , 1996, The New England journal of medicine.

[500]  C. Held,et al.  Effects of metoprolol vs verapamil in patients with stable angina pectoris. The Angina Prognosis Study in Stockholm (APSIS) , 1996, European heart journal.

[501]  G. Diamond,et al.  Comparison of the sensitivity and specificity of exercise electrocardiography in biased and unbiased populations of men and women. , 1995, American heart journal.

[502]  M. Herbert,et al.  Effect of amlodipine, atenolol and their combination on myocardial ischemia during treadmill exercise and ambulatory monitoring. Canadian Amlodipine/Atenolol in Silent Ischemia Study (CASIS) Investigators. , 1995, Journal of the American College of Cardiology.

[503]  B. Gersh,et al.  The utility of clinical, electrocardiographic, and roentgenographic variables in the prediction of left ventricular function. , 1995, The American journal of cardiology.

[504]  M. Emond,et al.  Long‐term Survival of Medically Treated Patients in the Coronary Artery Surgery Study (CASS) Registry , 1994, Circulation.

[505]  M. Ferratini.  Risk of rebound phenomenon during nitrate withdrawal. , 1994, International journal of cardiology.

[506]  F. Harrell,et al.  Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty. , 1994, Circulation.

[507]  O. Divitiis,et al.  A double-blind comparison of nicorandil and metoprolol in stable effort angina pectoris , 1993, Cardiovascular Drugs and Therapy.

[508]  S. Yusuf,et al.  Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. , 1992, The New England journal of medicine.

[509]  E. J. Brown,et al.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.

[510]  M. Vandenburg,et al.  A large scale comparative study in general practice with nitroglycerin spray and tablet formulations in elderly patients with angina pectoris , 1992, European Journal of Clinical Pharmacology.

[511]  S. Rahimtoola,et al.  Response of angina and ischemia to long-term treatment in patients with chronic stable angina: a double-blind randomized individualized dosing trial of nifedipine, propranolol and their combination. , 1992, Journal of the American College of Cardiology.

[512]  D A Clark,et al.  Cardiac catheterization 1990: a report of the Registry of the Society for Cardiac Angiography and Interventions (SCA&I). , 1991, Catheterization and cardiovascular diagnosis.

[513]  F. Harrell,et al.  Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease. , 1991, The New England journal of medicine.

[514]  Salim Yusuf,et al.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.

[515]  V Ionescu,et al.  [Silent myocardial ischemia]. , 1990, Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna.

[516]  B. Brent,et al.  Coronary artery bypass surgery in patients with left ventricular dysfunction. , 1986, The American journal of medicine.

[517]  G. Diamond.  A clinically relevant classification of chest discomfort. , 1983, Journal of the American College of Cardiology.

[518]  I. Ringqvist,et al.  Survival of Medically Treated Patients in the Coronary Artery Surgery Study (CASS) Registry , 1982, Circulation.

[519]  S. Goldberg,et al.  Refractory ergonovine-induced coronary vasospasm: importance of intracoronary nitroglycerin. , 1980, The American journal of cardiology.

[520]  G. Diamond,et al.  Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. , 1979, The New England journal of medicine.

[521]  K. Hammermeister,et al.  Variables predictive of survival in patients with coronary disease. Selection by univariate and multivariate analyses from the clinical, electrocardiographic, exercise, arteriographic, and quantitative angiographic evaluations. , 1979, Circulation.

[522]  L. Campeau.  Letter: Grading of angina pectoris. , 1976, Circulation.

[523]  M. Rutter,et al.  Genomic Risk Prediction of Coronary Artery Disease in 480,000 Adults Implications for Primary Prevention , 2019 .

[524]  National Institute for Health and Care Excellence (NICE) , 2019, The Grants Register 2020.

[525]  J. Piccini,et al.  Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation. , 2018, The New England journal of medicine.

[526]  Hiroaki Shimokawa,et al.  International standardization of diagnostic criteria for microvascular angina. , 2018, International journal of cardiology.

[527]  David Gunn Javaid Barmby,et al.  Study of two dose regimens of ticagrelor compared with clopidogrel in patients undergoing percutaneous coronary intervention for stable coronary artery disease (STEEL-PCI) , 2018 .

[528]  G. Thanassoulis,et al.  Fractional Flow Reserve–Guided Multivessel Angioplasty in Myocardial Infarction. , 2017, The New England journal of medicine.

[529]  Z. Ali,et al.  Comparison of Different Diastolic Resting Indexes to iFR Are They All Equal? , 2017 .

[530]  R. Brook,et al.  Air Pollution and Cardiometabolic Disease: An Update and Call for Clinical Trials. , 2017, American journal of hypertension.

[531]  M. Piano.  Alcohol’s Effects on the Cardiovascular System , 2017, Alcohol research : current reviews.

[532]  D. Berman,et al.  Long term prognostic utility of coronary CT angiography in patients with no modifiable coronary artery disease risk factors: Results from the 5 year follow-up of the CONFIRM International Multicenter Registry. , 2016, Journal of cardiovascular computed tomography.

[533]  Jeroen J. Bax,et al.  [2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)]. , 2016, Giornale italiano di cardiologia.

[534]  R. Califf,et al.  Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes. , 2015, The New England journal of medicine.

[535]  U. Sechtem,et al.  Pharmacotherapy for coronary microvascular dysfunction. , 2015, European heart journal. Cardiovascular pharmacotherapy.

[536]  Helmut Baumgartner,et al.  ESC / EACTS Guidelines on myocardial revascularization , 2014 .

[537]  T. Marwick,et al.  Prognostic value of stress imaging after revascularization: a systematic review of stress echocardiography and stress nuclear imaging. , 2014, American heart journal.

[538]  Guidelines for diagnosis and treatment of patients with vasospastic angina (Coronary Spastic Angina) (JCS 2013). , 2014, Circulation journal : official journal of the Japanese Circulation Society.

[539]  M. Taskinen,et al.  ESC/EAS Guidelines for the Management of Dyslipidaemias , 2013 .

[540]  U. Sechtem,et al.  Coronary vasomotor abnormalities in patients with stable angina after successful stent implantation but without in-stent restenosis , 2013, Clinical Research in Cardiology.

[541]  B. Gersh,et al.  ESC guidelines on the management of stable coronary artery disease — addenda The Task Force on the management of stable coronary artery disease of the European Society of Cardiology , 2013 .

[542]  M. Tendera,et al.  Antianginal Efficacy and Safety of Ivabradine Compared with Amlodipine in Patients with Stable Effort Angina Pectoris , 2012, Drugs.

[543]  B. Dong,et al.  Long-term beta blockers for stable angina: systematic review and meta-analysis. , 2012, European journal of preventive cardiology.

[544]  J. Caro.  ESC/EACTS Guidelines on the management of valvular heart disease , 2012 .

[545]  S. Werns.  Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes , 2011 .

[546]  B. J. Gersh.  Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials , 2011 .

[547]  B. Gersh,et al.  Angiographic Versus Functional Severity of Coronary Artery Stenoses in the FAME Study: Fractional Flow Reserve Versus Angiography in Multivessel Evaluation , 2011 .

[548]  Michael Marber,et al.  Sensitive troponin I assay in early diagnosis of acute myocardial infarction , 2010 .

[549]  J. Goebel.  Prevention of Disease Progression by Cardiac Resynchronization Therapy in Patients With Asymptomatic or Mildly Symptomatic Left Ventricular Dysfunction: Insights From the European Cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) Trial , 2010 .

[550]  N. Toma.  Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of Ticagrelor versus Clopidogrel in patients with stable coronary artery disease. The ONSET/OFFSET study. , 2010, Maedica.

[551]  A. Gorgels,et al.  Effectiveness of nurse-delivered cardiovascular risk management in primary care: a randomised trial. , 2010, The British journal of general practice : the journal of the Royal College of General Practitioners.

[552]  B. Gersh.  Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial , 2009 .

[553]  W. Howard.  Effect of Lowering LDL Cholesterol Substantially Below Currently Recommended Levels in Patients With Coronary Heart Disease and Diabetes: The Treating to New Targets (TNT) study , 2008 .

[554]  Bengt Jönsson,et al.  [Guidelines on diabetes, pre-diabetes, and cardiovascular diseases]. , 2007, Revista espanola de cardiologia.

[555]  L. Marcoff.  Transient ST-Segment Depression During Paroxysms of Atrial Fibrillation in Otherwise Normal Individuals Relation With Underlying Coronary Artery Disease , 2007 .

[556]  R. Day,et al.  Clinical Pharmacokinetics and Pharmacodynamics of Allopurinol and Oxypurinol , 2007, Clinical pharmacokinetics.

[557]  John D Friedman,et al.  Diagnostic accuracy of rest/stress ECG-gated Rb-82 myocardial perfusion PET: Comparison with ECG-gated Tc-99m sestamibi SPECT , 2006, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[558]  Ian G. Harnik.  Heart-rate profile during exercise as a predictor of sudden death. , 2005, The New England journal of medicine.

[559]  Shah Ebrahim,et al.  European guidelines on cardiovascular disease prevention in clinical practice , 2004 .

[560]  Eric J Topol,et al.  Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. , 2004, JAMA.

[561]  G. Mayer,et al.  Informational contribution of noninvasive screening tests for coronary artery disease in patients on chronic renal replacement therapy. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[562]  R. Cappato,et al.  A Randomized Comparison of Antiarrhythmic Drug Therapy with Implantable Defibrillators in Patients Resuscitated from Cardiac Arrest: the Cardiac Arrest , 2000 .

[563]  N Freemantle,et al.  beta Blockade after myocardial infarction: systematic review and meta regression analysis. , 1999, BMJ.

[564]  Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Scientific Steering Committee on behalf of the Simon Broome Register Group. , 1999, Atherosclerosis.

[565]  K. Fox,et al.  The Total Ischaemic Burden European Trial (TIBET). Effects of atenolol, nifedipine SR and their combination on the exercise test and the total ischaemic burden in 608 patients with stable angina. The TIBET Study Group. , 1996, European heart journal.

[566]  W. Wallace,et al.  Comparison of nifedipine gastrointestinal therapeutic system and atenolol on antianginal efficacies and exercise hemodynamic responses in stable angina pectoris. , 1994, The American journal of cardiology.

[567]  L. Miller.  Transplant coronary artery disease. , 1992, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[568]  G. Döring.  Antianginal and Anti‐Ischemic Efficacy of Nicorandil in Comparison with Isosorbide‐5‐Mononitrate and Isosorbide Dinitrate: Results from Two Multicenter, Double‐Blind, Randomized Studies with Stable Coronary Heart Disease Patients , 1992, Journal of cardiovascular pharmacology.

[569]  R. Wenzel.  Diuretics in heart failure. , 1986, Lancet.

[570]  Weiren Chen,et al.  Clinical Interventions in Aging Dovepress Medical Treatment and Long-term Outcome of Chronic Atrial Fibrillation in the Aged with Chest Distress: a Retrospective Analysis versus Sinus Rhythm , 2022 .